| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 16 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 3 | LEVETIRACETAM | 16 |
| 4 | DEXAMETHASONE | 15 |
| 5 | DEXAMETHASONE 1.5 MG | 15 |
| 6 | RIVASTIGMINE | 14 |
| 7 | CARBAMAZEPINE | 13 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| 9 | LEVETIRACETAM INJECTION | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 1 | L-GLUTAMINE | 1 | 0.0028 |
| 2 | TENECTEPLASE | 4 | 0.0025 |
| 3 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 4 | NITROUS OXIDE | 4 | 0.0018 |
| 5 | ACYCLOVIR SODIUM | 2 | 0.0016 |
| 6 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 7 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 8 | RIVASTIGMINE | 14 | 0.0007 |
| 9 | TREOSULFAN | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 35 |
| 1 | Benzodiazepine [EPC] | 23 |
| 2 | Alkylating Drug [EPC] | 21 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 4 | Atypical Antipsychotic [EPC] | 14 |
| 5 | Cholinesterase Inhibitor [EPC] | 14 |
| 6 | Mood Stabilizer [EPC] | 14 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 8 | Proton Pump Inhibitor [EPC] | 12 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinesterase Inhibitor [EPC] | 14 | 0.0007 |
| 1 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Glinide [EPC] | 1 | 0.0001 |